Proteasome Inhibitor
-
PD150606 (Standard)
0 ImagesCat. No.: HY-100529RCAS No.: 179528-45-1PD150606 (Standard) is the analytical standard of PD150606 (HY-100529). This product is intended for research and analytical applications. PD 150606 is a selective, cell-permeable non-peptide calpain inhibitor with Ki values of 0.21 μM and 0.37 μM for μ- and m-calpains respectively, which is neuroprotective.
-
10-Undecenoic acid (copper)
0 ImagesCat. No.: HY-B0914BCAS No.: 35322-29-3Synonyms: Undecylenic acid (copper)10-Undecenoic acid copper (Undecylenic acid copper) is an antifungal agent. 10-Undecenoic acid copper inhibits Aβ oligomerization, scavenges ROS and inhibits μ-calpain activity. 10-Undecenoic acid copper has neuroprotective effects. 10-Undecenoic acid copper has anticancer effects on a variety of tumors. 10-Undecenoic acid copper inhibits C. albicans biofilm formation and MRSA infection. 10-Undecenoic acid copper inhibits quorum sensing signals of Bacillus subtilis and Pseudomonas aeruginosa.
-
RID-F
0 ImagesCat. No.: HY-113824CAS No.: 1020853-03-5Synonyms: Ridaifen-FRID-F (Ridaifen-F), a Tamoxifen (HY-13757A) derivative, is a nonpeptidic proteasome inhibitor. RID-F inhibits human 20S proteasome activity, with IC50s of 0.64, 0.34, and 0.43 μM for CT-L, T-L, and PGPH, respectively.
-
Chymase-IN-2
0 ImagesCat. No.: HY-U00282CAS No.: 936366-22-2Chymase-IN-2 is a chymase modulator which is useful in the treatment of inflammatory and serine protease mediated disorders.
-
Neurodegenerative Disorder-Targeting Compound 1
0 ImagesCat. No.: HY-U00362CAS No.: 1254698-39-9Neurodegenerative Disorder-Targeting Compound 1 is a calpain inhibitor extracted from patent WO2010128102A1, compound example 63.
